167
別添5
研究成果の刊行に関する一覧表
書籍
著者氏名 論文タイトル名 書籍全体の
編集者名 書 籍 名 出版社名 出版地 出版年 ページ
（編集） 片渕秀隆，
楫 靖 JSAWI発 一 冊でわかる婦 人科腫瘍の画 像診断 モダ リ テ ィ ・ 解 剖・病理・診 断・治療フォ ローアップ・
ピットフォー ル
文光堂 日本 2019
青木大輔，
片渕秀隆，
三上幹男
子宮頸癌 日本癌治療
学会，
日本病理学 会
領域横断的が ん取扱い規約 第１版
金原出版 日本 2019 235-251
青木大輔，
片渕秀隆，
三上幹男
子宮体癌 日本癌治療
学会，
日本病理学 会
領域横断的が ん取扱い規約 第１版
金原出版 日本 2019 253-263
雑誌
発表者氏名 論文タイトル名 発表誌名 巻号 ページ 出版年 Takayama T, Y
amaki C, Haya kawa M, Higas hi T, Toh Y, W akao F.
Development of a ne w tool for better soci al recognition of can cer information and support activities un der the national can cer control policy in Japan.
J Public Hea lth Manag P ract
in press 2020
Toh Y, Numasa ki H, Tachimori Y, Uno T, Jing u K., Nemoto K, Matsubara H.
Current status of ra diotherapy for patien ts with thoracic esop hagealcancer in Japa n, based on the Com prehensive Registry of EsophagealCancer in Japan from 2009 to 2011 by the Jap an Esophageal Societ y.
Esophagus 17 25-32 2020
168 Toh Y, Yamamo
to H, Miyata H, Gotoh M, W atanabe M, Mat subara H, Kake ji Y, Seto Y.
Significance of the b oard‑certified surge on systems and clini cal practice guideline adherence to surgic al treatment of esop hageal cancer in Jap an: a questionnaire s urvey of departments registered in the N ational Clinical Data base.
Esophagus 16 362-370 2019
Nemoto K, Kaw ashiro S, Toh Y, Numasaki H, Tachimori Y, Uno T, Jingu K, Matsubara H.
Comparison of the ef fects of radiotherapy doses of 50.4 Gy an d 60 Gy on outcome s of chemoradiothera py for thoracic esoph ageal cancer: subgro up analysis based on the Comprehensive Registry of Esophage al Cancer in Japan f rom 2009 to 2011 by the Japan Esophage al Society.
Esophagus 17 122-126 2020
Jingu K, Numa saki H, Toh Y, Nemoto K, Uno T, Doki Y, Ma tsubara H.
Chemoradiotherapy a nd radiotherapy alon e in patients with es ophageal cancer aged 80 years or older b ased on the Compre hensive Registry of Esophageal Cancer i n Japan.
Esophagus in press 2020
Motoyama S, Y amamoto H, Mi yata H, Yano M, Yasuda T, Ohira M, Kajiy ama Y, Toh Y, Watanabe M., Kakeji Y., Seto Y., Doki Y., Ma tsubara H.
Impact of certificatio n status of the instit ute and surgeon on short-term outcomes after surgery for tho racic esophageal canc er: evaluation using data on 16,752 patie nts from the Nationa l Clinical Database i n Japan.
Esophagus 17 41-49 2020
Uchihara T, Yo shida N, Baba Y, Nakashima Y, Kimura Y, S aeki H, Takeno S, Sadanaga N, Ikebe M, Mo rita M, Toh Y, Nanashima A, Maehara Y, Ba ba H.
Esophageal Position Affects Short-Term O utcomes After Minim ally Invasive Esopha gectomy: A Retrospec tive Multicenter Stu dy.
World J Sur
g 44 831-837 2020
169 Motoyama S, M
aeda E, Yano M, Yasuda T, Ohira M, Doki Y, Toh Y, Higa shi T, Matsubar a H, Japan Eso phageal Society.
Appropriateness of t he institute certificat ion system for esoph ageal surgeries by th e Japan Esophageal Society: evaluation of survival outcomes u sing data from the National Database of Hospital-Based Can cer Registries in Jap an.
Esophagus 16 114-121 2019
Tachimori Y, O zawa S, Numas aki H, Ishihara R, Matsubara H, Muro K, Oy ama T, Toh Y, Udagawa H, U no T, Registrati on Committee f or Esophageal Cancer of the J apan Esophagea l Society.
Comprehensive regist ry of esophageal can cer in Japan, 2012.
Esophagus 16 221-245 2019
Kitagawa Y, Un o T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Tak euchi H, Toh Y, Doki Y, Naom oto Y, Nemoto K, Booka E, M atsubara H, Mi yazaki T, Muto M, Yanagisawa A, Yoshida M.
Esophageal cancer pr actice guidelines 201 7 edited by the Japa n Esophageal Societ y: part 1.
Esophagus 16 1-24 2019
Kitagawa Y, Un o T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Tak euchi H, Toh Y, Doki Y, Naom oto Y, Nemoto K, Booka E, M atsubara H, Mi yazaki T, Muto M, Yanagisawa A, Yoshida M.
Esophageal cancer pr actice guidelines 201 7 edited by the Japa n Esophageal Societ y: part 2.
Esophagus 16 25-43 2019
170 Yamamoto M, S
himokawa M, K awano H, Ohta M, Yoshida D, Minami K, Ike be M, Morita M, Toh Y.
Benefits of laparosco pic surgery compared to open standard su rgery for gastric carc inoma in elderly pati ents: propensity scor e-matching analysis.
Surg Endosc 33 510-519 2019
Yoshida N, Ya mamoto H, Bab a H, Miyata H, Watanabe M, Toh Y, Matsuba ra H, Kakeji Y, Seto Y.
Can Minimally Invas ive Esophagectomy R eplace Open Esophag ectomy for Esophage al Cancer? Latest A nalysis of 24,233 Eso phagectomies From t he Japanese Nationa l Clinical Database.
Ann Surg in press 2019
Committee for Scientific Affair s, The Japanese Association for Thoracic Surge ry. Shimizu H, Endo S, Natsug oe S, Doki Y, Hirata Y, Koba yashi J, Motom ura N, Nakano H, Nishiida H, Okada M, Saiki Y, Saito A, Sa to Y, Tanemoto K, Toh Y, Tsu kihara H, Wak ui S, Yokomise H, Masuda M, Yokoi K, Okita Y.
Thoracic and cardiov ascular surgery in J apan in 2016 : Annu al report by The Jap anese Association for Thoracic Surgery.
Gen Thorac Cardiovasc S urg
67 377-411 2019
Hasegawa K, S himada M, Nis hiyama M, et a l. (外10名12番目).
A phase 2 study of i ntraperitoneal carbo platin plus intraveno us dose-dense paclita xel in front-line trea tment of suboptimal residual ovarian ca ncer
Br J Cancer 2020 Jan 3
1.
doi: 10.1038/
s41416-020-0 734-9. [Epub ahead of pr int]
Hirata K, Ima mura M, Nishiy ama M. (外17名2 0番目).
Current status of sit e-specific cancer regi stry system for the clinical researches: a iming for future cont ribution by the asse ssment of present m edical care.
Int J Clin O
ncol 24(9) 1161-1168 2019
171 S Shimizu K,
Goto Y, Nishiya ma M, et al. (外 11名13番目).
Stathmin-1 Is a Use ful Diagnostic Marke r for High-Grade Lu ng Neuroendocrine T umors
Ann Thorac
Surg 108(1) 235-243 2019
大竹秀幸，高石清 美，宮原陽，田代 浩徳，田中信幸，
福間啓造，宮村伸 一，片渕秀隆
平成28年熊本地震によ る子宮がん検診事業へ の影響に関する実態調 査：震災後1年目の報告
熊本産科婦人 科学会雑誌
63 39-45 2019
齋藤文誉，片渕秀 隆
子宮体がんの標準治療
ライフライン 21 がんの先 端医療
33 26-29 2019
境健爾，岸裕人，
大竹秀幸，濱口裕 光，吉田稔，後藤 慶次，樋田直美，
内山恵美，中川実 優，宮本伸枝，江 原 美 香 ， 安 達 美 樹，宇宿功市郎，
片渕秀隆
熊本県におけるがん診 療連携活動の現状と課 題
癌と化学療法
46 1151-1157 2019
小 寺 千 聡 ， 坂 口 勲，大場隆，片渕 秀隆
災害時小児・周産期の 活 動 の 実 際 と 問 題 点 平成28年（2016年）熊 本地震 産科
周産期医学
49 1241-1245 2019
Watanabe T, M ikami M, Katab uchi H, Kato S, Kaneuchi M, Takahashi M, Nakai H, Naga se S, Niikura H, Mandai M, Hirashima Y, Y anai H, Yamag ami W, Kamita ni S, Higashi T
Quality indicators for cervical cancer care in Japan
Journal of G ynecologic O ncology
29（6） e83 2019
Ebina Y, Mika mi M, Nagase S, Tabata T, K aneuchi M, Tas hiro H, Mandai M, Enomoto T, Kobayashi Y, Katabuchi H, Y aegashi N, Uda gawa Y, Aoki D
Japan Society of Gy necologic Oncology G uidelines 2017 for th e Treatment of Uteri ne Cervical Cancer
Journal of C linical Oncol ogy
24 1-19 2019
172 Sunami E, Kus
umoto T, Ota M, Sakamoto Y, Yoshida K, To mita N, Maeda A, Teshima J, Okabe M, Tana ka C, Yamauchi J, Itabashi M, Kotake K, Tak ahashi K, Baba H, Boku N, Ai ba K, Ishiguro M, Morita S, T akenaka N, Ok ude R, Sugihar a K.
S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuva nt Chemotherapy in Patients With High-r isk Stage III Colon Cancer (ACTS-CC 0 2): A Randomized, O pen-label, Multicente r, Phase III Superior ity Trial.
Clin Colorect
al Cancer 19(1) 22-31 2020
Iihara H, Shim okawa M, Haya shi T, Kawazoe H, Saeki T, Ai ba K, Tamura K.
A Nationwide, Multi center Registry Stud y of Antiemesis for Carboplatin-Based C hemotherapy-Induced Nausea and Vomiti ng in Japan．
The Oncologi
st 24 1–8 2019
Yoshida I, Tam ura K, Miyamot o T, Shimokawa M, Takamatsu Y, Nanya Y, M atsumura I, Go toh M, Igarashi T, Takahashi T, Aiba K, Ku magai K, Ishiza wa K, Kurita N, Usui N, Hat ake K.
Prophylactic Antieme tics for Haematologic al Malignancies: Pro spective Nationwide Survey Subset Analy sis in Japan.
In Vivo 33(4) 1355-1362. 2019
Shimokawa M, Hayashi T, Kog awa T, Matsui R, Mizuno M, Kikkawa F, Sae ki T, Aiba K, T amura K.
Evaluation of combin ation antiemetic ther apy on CINV in pati ents with gynecologi c cancer receiving T C chemotherapy.
Anticancer R
es 39(1) 225-230. 2019
Kubo N, Shirab
e K. Treatment strategy f or isolated bile leaka ge after hepatectom y: Literature review.
Ann Gastroe
nterol Surg 4(1) 47-55 2019
173 Yamanaka T, H
arimoto N, Yok obori T, Muran ushi R, Hoshino K, Hagiwara K, Gantumur D, Handa T, Is hii N, Tsukagos hi M, Igarashi T, Tanaka H, Watanabe A, K ubo N, Araki K, Shirabe K.
Nintedanib inhibits i ntrahepatic cholangio carcinoma aggressive ness via suppression of cytokines extract ed from activated ca ncer-associated fibrob lasts.
Br J Cancer 2020
Igarashi T, Shi mizu K, Usui K, Yokobori T, Ohtaki Y, Naka zawa S, Obayas hi K, Yajima T, Nobusawa S, Ohkawa T, Kat oh R, Motegi Y, Ogawa H, Har imoto N, Ichiha ra T, Mitani Y, Yokoo H, Mogi A, Shirabe K.
Significance of RAS mutations in pulmon ary metastases of pa tients with colorectal cancer.
Int J Clin O
ncol 2019
Kurozumi S, In oue K, Matsum oto H, Fujii T, Horiguchi J, Oy ama T, Kurosu mi M, Shirabe K.
Clinicopathological v alues of PD-L1 expre ssion in HER2-positi ve breast cancer.
Sci Rep 9(1) 16662 2019
Yokobori T, Yaz awa S, Asao T, Nakazawa N, Mogi A, Sano R, Kuwano H, Kaira K, Shirab e K.
Fucosylated α1-acid glycoprotein as a bio marker to predict pr ognosis following tu mor immunotherapy of patients with lung cancer.
Sci Rep 9(1) 14503 2019
Harimoto N, H oshino K, Mura nushi R, Hagiw ara K, Yamana ka T, Ishii N, Tsukagoshi M, Igarashi T, Tan aka H, Watana be A, Kubo N, Araki K, Hosou chi Y, Suzuki H, Arakawa K, Hirai K, Fuka zawa T, Ikota H, Shirabe K.
Prognostic significan ce of neutrophil-lym phocyte ratio in rese ctable pancreatic ne uroendocrine tumors with special referen ce to tumor-associate d macrophages.
Pancreatolog
y 19(6) 897-902 2019
174 Ishii N, Harimo
to N, Araki K, Muranushi R, Hoshino K, Hag iwara K, Gantu mur D, Yaman aka T, Tsukago shi M, Igarashi T, Tanaka H, Watanabe A, K ubo N, Shirabe K.
Preoperative Mac-2 binding protein glyco sylation isomer level predicts postoperati ve ascites in patient s with hepatic resect ion for hepatocellula r carcinoma.
Hepatol Res
49(12) 1398-1405 2019
Kurozumi S, Jo seph C, Sonbul S, Alsaeed S, K ariri Y, Aljohan i A, Raafat S, Alsaleem M, Og den A, Johnsto n SJ, Aleskand arany MA, Fujii T, Shirabe K, Caldas C, Asha nkyty I, Dalton L, Ellis IO, De smedt C, Green AR, Mongan N P, Rakha EA.
A key genomic subty pe associated with ly mphovascular invasio n in invasive breast cancer.
Br J Cancer 120(12) 1129-1136 2019
Igarashi T, Har imoto N, Matsu mura N, Sugiya ma M, Araki K, Yokobori T, Ko sone T, Takagi H, Aishima S, Yokoo H, Shira be K.
Fairly rare small-dia meter hepatocellular carcinoma with right adrenal gland meta stasis having an infe rior vena cava tumor thrombus: a case re port.
Surg Case R
ep 5(1) 170 2019
Igarashi T, Har imoto N, Nobus awa S, Yoshida Y, Yamanaka T, Hagiwara K, Hoshino K, Ish ii N, Tsukagosh i M, Watanabe A, Kubo N, Ara ki K, Yokobori T, Yokoo H, Sh irabe K.
Evaluation of KRAS Mutation Status in a Patient With Conco mitant Pancreatic N euroendocrine Neopla sm and Intraductal Papillary Mucinous Neoplasm.
Pancreas 48(5) e34-e35 2019
渡邊清高 医療健康報道の質を探 る―メディアドクター で記事を「科学」する.
日本ヘルスコ ミュニケーシ ョン学会雑誌
28 Web 2019
175 渡邊清高, 有賀悦
子, 橋本俊一, 堀 江 大 輔, 坂 本 義 一, 小澤盛博, 坂 井元, 渡邊友浩, 田中由紀, 武田忠 利, 関順彦
帝京大学中学校・高等 学校における中学1年 生を対象としたがん教 育授業
帝京医学雑誌 42(2) 51‐60 2019
大 坂 巌, 渡 邊 清 高, 志真泰夫, 倉 持雅代, 谷田憲俊
わが国におけるWHO 緩和ケア定義の定訳‐
デルファイ法を用いた 緩和ケア関連18団体に よる共同作成
Palliative Ca
re Research 14(2) 61-66 2019
